Toxicological Research

Korean Society of Toxicology & Korea Environmental Mutagen Society (한국독성학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of Embryotoxic Potential of Olaquindox and Vitamin A in Micromass Culture and in Rats

  • Kang, Hwan-Goo (National Veterinary Research and Quarantine Service) ;
  • Ku, Hyun-Ok (National Veterinary Research and Quarantine Service) ;
  • Jeong, Sang-Hee (GLP Research Center, College of Natural Sciences, Hoseo University) ;
  • Cho, Joon-Hyoung (National Veterinary Research and Quarantine Service) ;
  • Son, Seong-Wan (National Veterinary Research and Quarantine Service)
  • Received : 2010.05.04
  • Accepted : 2010.05.31
  • Published : 2010.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Limb bud (LB) and central nerve system (CNS) cells were prepared from 12.5 day old pregnant female Crj:CD (SD) rats and treated with olaquindox and vitamin A. Cytotoxicity and inhibition on differentiation were measured in each cell. Three doses of olaquindox (4, 21 and 100 mgkg), and 0.2 and 75 mg/kg of vitamin A were administered to pregnant rat for 11 days from $6^{th}$ to $16^{th}$ of pregnancy. $IC_{50}$ values of olaquindox for proliferation and differentiation in CNS cell were 22.74 and $28.32\;{\mu}g/ml$ and 79.34 and $23.29\;{\mu}g/ml$ in LB cell and those values of vitamin A were 8.13 and $5.94\;{\mu}g/ml$ in CNS cell and 0.81 and $0.05\;{\mu}g/ml$ in LB cell, respectively. Mean body weights of pregnant rats were decreased at high dose of olaquindox (110 mg/kg) but relative ovary weight, number of corpus lutea, and number of implantation were not changed. Resorption and dead fetus were increased at high dose of olaquindox, and relative ovary weight, the number of corpus lutea and implantation, and sex ratio of male to female were not significantly changed in all dose of olaquindox. Mean fetal and placenta weights were significantly (p < 0.01) decreased in rats of high group. Seven fetuses out of 103 showed external anomaly like bent tail, and 10 out of 114 fetuses showed visceral anomalies at high group. The ossification of sternebrae and metacarpals were significantly (p < 0.01) increased by low and middle dose of olaquindox but it was significantly (p < 0.01) prohibited by high dose of olaquindox. In rats treated with vitamin A, the resorption and dead fetus were increased by high dose. Mean fetal weights were significantly (p < 0.01) increased by low dose but significantly (p < 0.01) decreased by high dose. Thirty four fetuses out of 52 showed external anomaly; bent tail (1), cranioarchschisis (14), exencephaly (14), dome shaped head (22), anophthalmia (15), brcahynathia (10) and others (19). Forty five fetuses out of 52 showed soft tissue anomaly; cleft palate (42/52) and anophthalmia (22/52) by high dose of vitamin A. Sixty one fetuses out of 61 (85.2%) showed skull anomaly; defect of frontal, partial and occipital bone (21/61), defect of palatine bone (52/61) and others (50/61). In summary, we support that vitamin A is strong teratogen based on our micromass and in vivo data, and olaquindox has a weak teratogenic potential in LB cell but not in CNS cell. We provide the in vivo evidence that a high dose of olaquindox could have weak embryotoxic potential in rats.

Keywords

References

  1. Aulthouse, A.L. and Hitt, D.C. (1994). The teratogenic effects of valproic acid in human chondrogenesis in vitro. Teratology, 49, 208-217. https://doi.org/10.1002/tera.1420490317
  2. Belhadjali, H., Marguery, M.C., Journe, F., Giordano-Labadie, F., Lefebvre, H. and Bazex, J. (2002). Allergic and photoallergic contact dermatitis to Olaquindox in a pig breeder with prolonged photosensitivity. Photodermatol. Photoimmunol. Photomed., 18, 52-53. https://doi.org/10.1034/j.1600-0781.2002.180112.x
  3. Beutin, L., Preller, E. and Kowalski, B. (1981). Mutagenicity ofquindoxin, its metabolites, and two substituted quinoxaline-di-N-oxides. Antimicrob. Agents. Chemother., 20, 336-343. https://doi.org/10.1128/AAC.20.3.336
  4. Bronsch, K., Schneider, D. and Rigal-Antonelli, F. (1976).[Olaquindox - a new growth promoter in animal nutrition. 1.Effectiveness in raising piglets]. Z. Tierphysiol. Tierernahr. Futtermittelkd., 36, 211-221.
  5. Commission of the European Communities, Commission Regulation 2788/98, Off. J. Eur. Communities L347 (31-32), 1998, 12- 23.
  6. Chen, Q., Tang, S., Jin, X., Zou, J., Chen, K., Zhang, T. and Xiao, X. (2009). Investigation of the genotoxicity of quinocetone, carbadox and olaquindox in vitro using Vero cells. Food Chem. Toxicol.,47, 328-334. https://doi.org/10.1016/j.fct.2008.11.020
  7. Ding, M.X., Wang, Y.L., Zhu, H.L. and Yuan, Z.H. (2006). Effects of cyadox and olaquindox on intestinal mucosal immunity and on fecal shedding of Escherichia coli in piglets. J. Anim. Sci., 84, 2367-2373. https://doi.org/10.2527/jas.2005-564
  8. Flint, O.P. (1986). An in vitro test for teratogens: its practical application. Food Chem. Toxicol., 24, 627-631. https://doi.org/10.1016/0278-6915(86)90138-9
  9. Flint, O.P. (1993). In vitro tests for teratogens: desirable endpoints, test batteries and current status of the micromass teratogen test. Reprod. Toxicol., 7, 103-111. https://doi.org/10.1016/0890-6238(93)90075-I
  10. Flint, O.P. and Orton, T.C. (1984). An in vitro assay for teratogens with cultures of rat embryo midbrain and limb bud cells. Toxicol. Appl. Pharmacol., 76, 383-395. https://doi.org/10.1016/0041-008X(84)90020-6
  11. Guntakatta, M., Matthews, E.J. and Rundell, J.O. (1984). Development of a mouse embryo limb bud cell culture system for the estimation of chemical teratogenic potential. Teratog. Carcinog. Mutagen., 4, 349-364.
  12. Hao, L., Chen, Q. and Xiao, X. (2006). Molecular mechanism of mutagenesis induced by olaquindox using a shuttle vector pSP189/mammalian cell system. Mutat. Res., 599, 21-25. https://doi.org/10.1016/j.mrfmmm.2005.12.017
  13. Kidney, J.K. and Faustman, E.M. (1995). Modulation of nitrosourea toxicity in rodent embryonic cells by O6-benzylguanine, a depletor of O6-methylguanine-DNA methyltransferase. Toxicol. Appl. Pharmacol., 133, 1-11. https://doi.org/10.1006/taap.1995.1120
  14. Kistler, A. (1987). Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids. Arch. Toxicol., 60, 403-414. https://doi.org/10.1007/BF00302382
  15. Kistler, A. and Howard, W.B. (1990). Testing of retinoids for teratogenicity in vitro: use of micromass limb bud cell culture.Methods Enzymol., 190, 427-433. https://doi.org/10.1016/0076-6879(90)90048-6
  16. Lehmann, J.M., Jong, L., Fanjul, A., Cameron, J.F., Lu, X.P., Haefner, P., Dawson, M.I. and Pfahl, M. (1992). Retinoids selective for retinoid X receptor response pathways. Science,258, 1944-1946. https://doi.org/10.1126/science.1335166
  17. Liu, Z.Y., Huang, L.L., Chen, D.M., Dai, M.H., Tao, Y.F. andYuan, Z.H. (2010). The metabolism and N-oxide reduction of olaquindox in liver preparations of rats, pigs and chicken. Toxicol Lett., 195, 51-59. https://doi.org/10.1016/j.toxlet.2010.02.014
  18. Paulsen, D.F., Langille, R.M., Dress, V. and Solursh, M. (1988).Selective stimulation of in vitro limb-bud chondrogenesis by retinoic acid. Differentiation, 39, 123-130. https://doi.org/10.1111/j.1432-0436.1988.tb00087.x
  19. Paulsen, D.F. and Solursh, M. (1988). Microtiter micromass cultures of limb-bud mesenchymal cells. In Vitro Cell Dev. Biol., 24, 138-147. https://doi.org/10.1007/BF02623891
  20. Schneider, D., Bronsch, K. and Richter, L. (1976). [Olaquindox--a new growth promoting feed additive. II. Effect on the performance in swine fattening]. Z. Tierphysiol. Tierernahr. Futtermittelkd., 36, 241-248.
  21. Soprano, D.R., Tairis, N., Gyda, M., 3rd, Harnish, D.C., Jiang, H., Soprano, K.J. and Kochhar, D.M. (1993). Induction of RARbeta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency. Toxicol. Appl. Pharmacol., 122, 159-163. https://doi.org/10.1006/taap.1993.1183
  22. Staples, R.E. and Schenell, V.L. (1964). Refinements in rapidclearing technique in the KOH-alizarin red S method for fetalbone. Stain. Technol., 39, 61-63.
  23. Tzimas, G., Thiel, R., Chahoud, I. and Nau, H. (1997). The areaunder the concentration-time curve of all-trans-retinoic acid isthe most suitable pharmacokinetic correlate to the embryotoxicity of this retinoid in the rat. Toxicol. Appl. Pharmacol., 143, 436-444 https://doi.org/10.1006/taap.1997.8105
  24. WHO (1991). Joint FAO/WHO Expert Committee on Food Additives,WHO Food Additives Series 27, Olaquindox, ToxicologicalEvaluation of Certain Veterinary Drug Residues in Food(InChem;http://www.inchem.org).
  25. Willhite, C.C., Jurek, A., Sharma, R.P. and Dawson, M.I. (1992). Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein. Toxicol. Appl. Pharmacol.,112, 144-153. https://doi.org/10.1016/0041-008X(92)90290-9
  26. Wise, L.D., Clark, R.L., Rundell, J.O. and Robertson, R.T. (1990). Examination of a rodent limb bud micromass assay as a prescreen for developmental toxicity. Teratology, 41, 341-351. https://doi.org/10.1002/tera.1420410312
  27. Zanetti, N.C. and Solursh, M. (1984). Induction of chondrogenesis in limb mesenchymal cultures by disruption of the actin cytoskeleton. J. Cell. Biol., 99, 115-123. https://doi.org/10.1083/jcb.99.1.115